Xiaoping Zhou

MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition

Matthew Fell, Christian Mirescu, Kallol Basu et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 337 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Epigenetic PTEN Silencing in Malignant Melanomas without PTEN Mutation

Xiaoping Zhou, Oliver Gimm, Heather Hampel et al. · American Journal Of Pathology · 2000 · 273 citations · Full text

Medicine, Molecular Biology, Oncology +16

Germline Mutations in BMPR1A/ALK3 Cause a Subset of Cases of Juvenile Polyposis Syndrome and of Cowden and Bannayan-Riley-Ruvalcaba Syndromes*

Xiaoping Zhou, K Woodford-Richens, Rainer Lehtonen et al. · The American Journal of Human Genetics · 2001 · 257 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites

Xiaoping Zhou, Jean-Marc Hoang, Youjun Li et al. · Genes Chromosomes and Cancer · 1998 · 238 citations

Life Sciences, Genetics, Oncology +17

Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis

Xiaoping Zhou · Human Molecular Genetics · 2000 · 214 citations · Full text

Medicine, Oncology, Pathology +16